/Investor DB

WRF Capital — Full Portfolio

20 tracked investments · listed companies and verified rows first

2Morrow2morrowinc.cominApr 2021 · $1.5M

2Morrow provides evidence-based digital wellness programs delivered through a smartphone and web app, using Acceptance and Commitment Therapy principles to help people quit tobacco, manage stress, and change health behaviors.

Digital HealthMental HealthWellness & FitnessKirkland, US

Jo Masterson(Executive Officer, Director)inBrandon Masterson(Executive Officer)in

BoardJohn Koster(Director)Eric Larsen(Director)in

Co-investorsPortland Seed FundAlliance of Angels

Accipiter Biosciencesaccipiterbio.cominJul 2026

Accipiter Biosciences uses computational protein design to develop de novo, single-agent protein therapies that engage multiple cell-surface receptors at once, functioning as agonists.

AI & Machine LearningBiotechDeep TechSeattle, US

Matthew Bick(Executive Officer, Director, Promoter)inJavier Castellanos(Executive Officer, Director, Promoter)inHector De Jesus Rincon Arano(Executive Officer, Promoter)Heather Redman(Director)Randall Schatzman(Director)William Canestaro(Executive Officer)in

Co-investorsCreative Destruction Lab (CDL)Flying Fish VenturesArgonautic VenturesColumbus Venture PartnersPack Ventures

AnswerDashanswerdash.cominAug 2015 · $2.9M

Seattle, US

JACOB O. WOBBROCK(Executive Officer)inWILLIAM T. COLLERAN(Executive Officer, Director)ANDREW KO(Executive Officer)

BoardWILLIAM MCALEER(Director)inMARK UPSON(Director)MICHAEL FRIDGEN(Director)

Co-investorsCowles VenturesThe W FundVoyager Capital

Arzedaarzeda.comin𝕏Jul 2017 · $12M

Arzeda designs proteins and metabolic pathways using computational tools, including its Archytas protein design software and Scylax metabolic pathway design software.

AI & Machine LearningBiotechDeep TechFoodTechNew MaterialsSeattle, US

Alexandre Zanghellini(Co-Founder & Chief Executive Officer)inEric Althoff(Executive Officer, Director, Promoter)inDavid Baker(Co-founder and Scientific Advisor)Bill Baum(Director)inAndrew Ban(Executive Officer)Daniela Grabs(Executive Officer)

Co-investorsCirculate CapitalFall Line CapitalSofinnova PartnersSustainable Conversion VenturesContinental Grain CompanyLewis & Clark AgriFood+2 more

Bellwether BioinApr 2018

BiotechSeattle, US

Rahul Shendure(Executive Officer, Director, Promoter)inMatthew Snyder(Director)

Co-investorsThe W Fund

BirchAIbirch.aiin

Automates complex call center operations; acquired by Sagility Health.

Co-investorsAllen Institute for AI (AI2) IncubatorFlare Capital PartnersAI GrantRadical Ventures

dopl technologiesdopltechnologies.comin𝕏Jul 2026

Dopl develops a software platform that enables specialists to remotely operate medical devices, beginning with telerobotic ultrasound to deliver diagnostic care to underserved communities.

AI & Machine LearningHealthtechMedical DevicesRoboticsBothell, US

MonskySeslar

Co-investorsSpringTide Ventures100Km Ventures LlcDream Variation VenturesMeasuredTechstarsHustle Fund+2 more

Fred Hutchfredhutch.orgin𝕏

Fred Hutch is a cancer research institute that develops biomarkers, therapies, and stem cell products for research and clinical use, and provides data infrastructure and funding to commercialize discoveries into treatments and spinout companies.

BiotechHealthtechMedical DevicesSeattle, US

ISBsystemsbiology.orgin𝕏

The Institute for Systems Biology (ISB) is a research organization focused on systems biology science and education, including curriculum development, educator engagement, and student research programs.

Biotech

Nexgenianexgeniacorp.com

Nexgenia develops proprietary stimuli-responsive polymer-based reagents for molecular and cellular selection, diagnostics, and immunoassays.

BiotechDeep TechNew MaterialsSeattle, US

Ron Myers(Executive Officer, Director)

BoardSteven Gillis(Director)Charles P. Waite(Director)Martin Simonetti(Director)Stewart Parker(Director)David Urdal(Director)

Co-investorsThe W FundAlliance of Angels

Outpace Biooutpacebio.cominAug 2024

Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.

BiotechDeep TechMedical DevicesSeattle, US

Marc Lajoie(Founder)inScott Boyken(Founder)inStanley Riddell(Co-Founder and Scientific Advisor)Aaron Foster(Executive Officer)inCharity Scripture(Executive Officer)inEric Soller(Executive Officer)in

Co-investorsArtis VenturesRA CapitalAbstract VenturesATEL VenturesAtinum Investment Co. Ltd.Civilization Ventures Management, Llc+8 more

Phytelligencephytelligence.comJul 2017 · $7M

AgTechPullman, US

Amit Dhingra(Executive Officer, Director)Chris Leyerle(Executive Officer, Director)

BoardJack Snyder(Director)

Co-investorsKeiretsu Forum

Pronirasproniras.comFeb 2024

Proniras Corporation is a clinical-stage biotechnology company developing novel small-molecule therapeutics for substance use disorders and specialty central nervous system (CNS) conditions, including treatments for opioid withdrawal and seizure disorders.

BiotechHealthtechSeattle, US

CHRISTOPHER TOOMBS(Executive Officer)inLINDSAY RAYLE(Executive Officer, Promoter)M. Johnston Erwin(Director)David Schubert(Executive Officer, Promoter)

BoardSTEVEN GILLIS(Director)inThong Le(Executive Officer, Director, Promoter)

Co-investorsACCELERATOR LIFE SCIENCE PARTNERSAlexandriaARCH Venture Partners

Resolve Therapeuticsresolvetherapeutics.com

Biopharma company developing non-immunosuppressive drugs for autoimmune diseases.

James Posada, Ph.D.(Founder)in

Co-investorsNew Science VenturesEaston Capital

Talus Biotalus.bioin𝕏Seed · Jul 2024

Talus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts.

AI & Machine LearningBiotechDeep TechHealthtechSeattle, US

Alex Federation(Founder)inLindsay Pino(Founder)inAlex Federation, Ph.D.(Chief Executive Officer & Co-Founder)Lindsay Pino, Ph.D.(Chief Technology Officer & Co-Founder)

BoardOmri Amirav-Drory(Director)inJ. Seth Strattan(Director)in

Co-investorsFarvatn VentureFifty YearsFundersClubJude GomilaNFXPioneer+11 more

Uptake Medicaluptakemedical.comMay 2006 · $9M

Uptake Medical is a medical device company developing Bronchoscopic Thermal Vapor Ablation, a non-surgical, non-implant therapy that applies heated water vapor to ablate diseased lung tissue.

BiotechHealthtechMedical DevicesTustin, US

Robert Barry(Executive Officer, Promoter)Krista Mann(Executive Officer)R. King Nelson(Executive Officer, Director)in

BoardCarl Simpson(Director)David Singer(Director)inGeoff Brooke(Director)

Co-investorsArboretum VenturesGBS Venture Partners Ltd.Maverick CapitalMaverick Ventures

UWwashington.eduin𝕏

University of Washington is a public research institution offering undergraduate, graduate, and professional education across multiple campuses and disciplines including engineering, computer science, business, medicine, law, and environmental studies.

EdTechSeattle, US

Co-investorsShumo Chu

WSUwsu.edu

Washington State University is a public research institution operating six campuses across Washington state and online, offering academic programs in fields including health sciences, STEM, business, engineering, and social sciences.

EdTechPullman, US

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ApoGen BiotechnologiesMDmetrix

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.